These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 18242212)

  • 1. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses.
    Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Iwakura Y; Yoshikai Y
    J Immunol; 2010 Dec; 185(12):7671-80. PubMed ID: 21068411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
    Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
    J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.
    Boirivant M; Pallone F; Di Giacinto C; Fina D; Monteleone I; Marinaro M; Caruso R; Colantoni A; Palmieri G; Sanchez M; Strober W; MacDonald TT; Monteleone G
    Gastroenterology; 2006 Dec; 131(6):1786-98. PubMed ID: 17087939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate memory phenotype CD4+ T cells play a role in early protection against infection by Listeria monocytogenes in a CD30L-dependent manner.
    Umeda K; Sun X; Guo Y; Yamada H; Shibata K; Yoshikai Y
    Microbiol Immunol; 2011 Sep; 55(9):645-56. PubMed ID: 21699557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
    Shen C; Bullens D; Kasran A; Maerten P; Boon L; Aerts JM; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
    Int Immunopharmacol; 2004 Jul; 4(7):939-51. PubMed ID: 15182733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
    Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
    J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation.
    Beck PL; Li Y; Wong J; Chen CW; Keenan CM; Sharkey KA; McCafferty DM
    Gastroenterology; 2007 May; 132(5):1778-90. PubMed ID: 17449036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
    Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
    Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
    Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
    Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
    Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
    J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice.
    Katchar K; Kelly CP; Keates S; O'brien MJ; Keates AC
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1263-71. PubMed ID: 17272517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.